US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 85.430
  • +0.510+0.60%
Close Nov 21 16:00 ET
  • 85.430
  • 0.0000.00%
Post 16:20 ET
4.29BMarket Cap35.45P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 28, 2024
(Q1)Jun 29, 2024
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
(Q3)Dec 30, 2023
(Q2)Sep 30, 2023
(Q1)Jul 1, 2023
(FY)Apr 1, 2023
(Q4)Apr 1, 2023
(Q3)Dec 31, 2022
Total revenue
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
17.67%1.17B
14.87%304.42M
305.3M
Operating revenue
8.59%345.51M
7.98%336.17M
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
17.67%1.17B
14.87%304.42M
--305.3M
Cost of revenue
7.04%158.07M
11.93%161.25M
11.55%617.51M
12.97%167.38M
8.04%158.38M
5.78%147.67M
20.87%144.07M
13.51%553.56M
15.13%148.17M
146.59M
Gross profit
9.93%187.44M
4.58%174.92M
12.43%691.55M
12.58%175.91M
12.07%177.87M
8.00%170.51M
17.57%167.27M
21.68%615.1M
14.63%156.25M
158.71M
Operating expense
0.39%135.74M
18.98%135.17M
12.80%518.25M
21.90%147.96M
14.26%131.89M
21.65%135.21M
1.89%113.61M
5.78%459.45M
3.64%121.38M
115.43M
Selling and administrative expenses
-7.26%106.95M
15.79%108.25M
14.63%431.78M
24.47%121.68M
18.01%111.71M
25.31%115.32M
1.36%93.49M
10.74%376.68M
5.78%97.76M
--94.66M
Research and development costs
30.52%16.53M
14.24%14.45M
8.59%54.44M
1.36%15.86M
4.54%13.27M
16.24%12.67M
16.02%12.65M
7.12%50.13M
18.43%15.64M
--12.69M
Depreciation amortization depletion
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
-31.16%32.64M
-30.56%7.97M
--8.08M
-Depreciation and amortization
69.81%12.26M
66.88%12.47M
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
-31.16%32.64M
-30.56%7.97M
--8.08M
Operating profit
46.44%51.7M
-25.91%39.76M
11.34%173.3M
-19.87%27.94M
6.24%45.98M
-24.46%35.3M
74.40%53.66M
118.77%155.65M
81.64%34.87M
43.28M
Net non-operating interest income expense
-183.00%-6.99M
436.25%6.96M
11.02%-13.02M
-148.35%-6.53M
-84.74%-1.95M
56.44%-2.47M
60.76%-2.07M
14.55%-14.63M
32.10%-2.63M
-1.06M
Non-operating interest income
----
--6.96M
----
----
----
----
----
----
----
----
Non-operating interest expense
183.00%6.99M
----
-11.02%13.02M
148.35%6.53M
84.74%1.95M
-56.44%2.47M
-60.76%2.07M
-14.55%14.63M
-32.10%2.63M
--1.06M
Other net income (expense)
-2,303.93%-8.42M
2M
-96.02%382K
Special income (charges)
----
----
-2,303.93%-8.42M
423.56%2M
--0
----
----
-96.02%382K
--382K
--0
-Less:Impairment of capital assets
----
----
--10.42M
--0
--0
----
----
--0
--0
--0
-Gain on sale of business
----
----
423.56%2M
----
----
----
----
-96.02%382K
----
----
Income before tax
36.16%44.7M
-9.45%46.71M
7.40%151.87M
-28.24%23.41M
4.27%44.03M
-20.04%32.83M
102.36%51.59M
122.23%141.4M
112.87%32.63M
42.22M
Income tax
37.22%10.87M
-20.93%8.34M
31.94%34.31M
-6.04%3.05M
37.80%12.79M
0.79%7.92M
87.79%10.55M
28.38%26M
-41.94%3.24M
9.28M
Net income
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
Net income continuous Operations
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
--32.94M
Minority interest income
Net income attributable to the parent company
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.82%33.83M
-6.50%38.37M
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
Basic earnings per share
34.69%0.66
-7.41%0.75
2.20%2.32
-31.15%0.401
-4.62%0.62
-24.62%0.49
107.69%0.81
167.06%2.27
205.65%0.5825
0.65
Diluted earnings per share
37.50%0.66
-7.50%0.74
2.23%2.29
-29.82%0.4
-4.69%0.61
-25.00%0.48
110.53%0.8
166.67%2.24
200.00%0.57
0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Sep 28, 2024(Q1)Jun 29, 2024(FY)Mar 30, 2024(Q4)Mar 30, 2024(Q3)Dec 30, 2023(Q2)Sep 30, 2023(Q1)Jul 1, 2023(FY)Apr 1, 2023(Q4)Apr 1, 2023(Q3)Dec 31, 2022
Total revenue 8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M17.67%1.17B14.87%304.42M305.3M
Operating revenue 8.59%345.51M7.98%336.17M12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M17.67%1.17B14.87%304.42M--305.3M
Cost of revenue 7.04%158.07M11.93%161.25M11.55%617.51M12.97%167.38M8.04%158.38M5.78%147.67M20.87%144.07M13.51%553.56M15.13%148.17M146.59M
Gross profit 9.93%187.44M4.58%174.92M12.43%691.55M12.58%175.91M12.07%177.87M8.00%170.51M17.57%167.27M21.68%615.1M14.63%156.25M158.71M
Operating expense 0.39%135.74M18.98%135.17M12.80%518.25M21.90%147.96M14.26%131.89M21.65%135.21M1.89%113.61M5.78%459.45M3.64%121.38M115.43M
Selling and administrative expenses -7.26%106.95M15.79%108.25M14.63%431.78M24.47%121.68M18.01%111.71M25.31%115.32M1.36%93.49M10.74%376.68M5.78%97.76M--94.66M
Research and development costs 30.52%16.53M14.24%14.45M8.59%54.44M1.36%15.86M4.54%13.27M16.24%12.67M16.02%12.65M7.12%50.13M18.43%15.64M--12.69M
Depreciation amortization depletion 69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M-31.16%32.64M-30.56%7.97M--8.08M
-Depreciation and amortization 69.81%12.26M66.88%12.47M-1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M-31.16%32.64M-30.56%7.97M--8.08M
Operating profit 46.44%51.7M-25.91%39.76M11.34%173.3M-19.87%27.94M6.24%45.98M-24.46%35.3M74.40%53.66M118.77%155.65M81.64%34.87M43.28M
Net non-operating interest income expense -183.00%-6.99M436.25%6.96M11.02%-13.02M-148.35%-6.53M-84.74%-1.95M56.44%-2.47M60.76%-2.07M14.55%-14.63M32.10%-2.63M-1.06M
Non-operating interest income ------6.96M--------------------------------
Non-operating interest expense 183.00%6.99M-----11.02%13.02M148.35%6.53M84.74%1.95M-56.44%2.47M-60.76%2.07M-14.55%14.63M-32.10%2.63M--1.06M
Other net income (expense) -2,303.93%-8.42M2M-96.02%382K
Special income (charges) ---------2,303.93%-8.42M423.56%2M--0---------96.02%382K--382K--0
-Less:Impairment of capital assets ----------10.42M--0--0----------0--0--0
-Gain on sale of business --------423.56%2M-----------------96.02%382K--------
Income before tax 36.16%44.7M-9.45%46.71M7.40%151.87M-28.24%23.41M4.27%44.03M-20.04%32.83M102.36%51.59M122.23%141.4M112.87%32.63M42.22M
Income tax 37.22%10.87M-20.93%8.34M31.94%34.31M-6.04%3.05M37.80%12.79M0.79%7.92M87.79%10.55M28.38%26M-41.94%3.24M9.28M
Net income 35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M
Net income continuous Operations 35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M--32.94M
Minority interest income
Net income attributable to the parent company 35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.82%33.83M-6.50%38.37M1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M
Basic earnings per share 34.69%0.66-7.41%0.752.20%2.32-31.15%0.401-4.62%0.62-24.62%0.49107.69%0.81167.06%2.27205.65%0.58250.65
Diluted earnings per share 37.50%0.66-7.50%0.742.23%2.29-29.82%0.4-4.69%0.61-25.00%0.48110.53%0.8166.67%2.24200.00%0.570.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data